DOSEVUE
Desconocido
ORIGIN: Optical Fibre Dose Imaging for Adaptive Brachytherapy
DOSEVUE
participó en un
H2020:
H2020-ICT-2018-20
ORIGIN aims to deliver more effective, photonics-enabled, brachytherapy for cancer treatment through advanced real-time radiation dose imagi...
2019-11-05 - 2023-12-31 | Financiado
2019-11-05 - 2023-12-31 | Financiado
AMPHORA: ACOUSTIC MARKERS FOR ENHANCED REMOTE SENSING OF RADIATION DOSES
DOSEVUE
participó en un
H2020:
H2020-FETOPEN-2016-2017
Approximately 50% of all cancer patients receive radiation therapy as part of their treatment. The aim is hereby to maximise tumor irradiati...
2017-08-08 - 2022-04-30 | Financiado
2017-08-08 - 2022-04-30 | Financiado
* No se disponen de datos de la empresa actual.